Gentris

Gentris

  • 133 Southcenter Court Suite 400
  • Morrisville, North Carolina
  • 27560

Description

An accomplished financial leader with over 20 years of experience in both Fortune 50 (Life Sciences) and middle market publicly-traded and Private-Equity held companies, Pam Prior joined Gentris in 2013 as its Chief Financial Officer. Pam is focused on defining and maintaining the financial infrastructure to support the Gentris vision for continued growth and transformation. Over 17 years, Pam held a number of progressively responsible positions at DuPont, DuPont-Merck and DuPont Pharmaceuticals, and with the packaging subsidiary of Cardinal Health as their Corporate Controller.

LRA was acquired by Constella Group in November 2006 and Ms. Lineberry subsequently served as Vice President, Strategic Affairs for the new organization. Ms. Lineberry has more than 25 years of cross-functional pharmaceutical experience in basic and clinical research, as well as experience in business development and marketing. Prior to the founding of LRA, Ms.

At Gentris, we believe in providing the highest level of quality services to meet our customer's needs. From our CAP Accredited biorepository, to our CLIA regulated laboratory, we strive to be the leader in pharmacogenomics solutions.

At Gentris, we understand the advantages and utility of gene expression profiling in drug development. Well-designed studies can have a major impact on drug development. Our scientists have extensive experience working with clients to develop optimal study designs, sample collection protocols, and strategic application of pharmacogenomics in clinical studies.

Gentris has extensive expertise in implementing pharmacogenomics and biorepositories for clinical trials. Our team has implemented GLP and CLIA studies for biotech and pharma companies and has been involved in writing voluntary genomic data submissions and clinical protocols. Clients can benefit from 10 years of experience at the cutting edge of PGx testing by working with Gentris experts to plan new studies, troubleshoot assays or study designs, interpret data, etc.

Fact sheet

Number of employees
5-9

Products & services

Similar companies nearby